Newsletters

Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …

Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …

Hello, MAPS members and friends! In today’s news from MAPS: 1. FDA replies to DEA regarding Dr. Michael Mithoefer’s Schedule I license for MDMA/PTSD study; DEA should respond soon 2. Dr. Mithoefer …

Greetings, MAPS members! In this issue, we have a number of research news items as well as some notes from the MAPS staff: About research: 1. Great 12/2/03 NY Times article on Ricaurte’s MDMA research …

Happy Autumn, MAPS members! It’s been a while since the last email update, and we’ve been quite busy — as you’ll read here. In this issue: 1. DEA agents inspect Dr. Mithoefer’s …

MAPS News 9/24/03: A historic day Hello, MAPS members- We have wonderful news! Yesterday (Tuesday, September 23, 2003), the Institutional Review Board reviewing Dr. Mithoefer’s MDMA/PTSD protocol …

Greetings, MAPS members! This is the third edition of the MAPS news email update. We’re happy to report several items of progress in both research projects and in our efforts at outreach and education. …

Happy Summer, MAPS members! This is the second edition of our newly-created email update for members. We have several items of encouraging news to report: In medical marijuana news: Grant awarded for vaporizer …

Greetings, MAPS members! We hope you’re enjoying the Spring 2003 MAPS bulletin! If you haven’t received your copy, let us know. (International members will have to wait a bit longer.) In an …